Status:

UNKNOWN

The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases

Lead Sponsor:

Lithuanian University of Health Sciences

Conditions:

Allergic Asthma

Allergic Rhinitis

Eligibility:

All Genders

18-50 years

Brief Summary

The prevalence of allergic diseases, especially airway allergic diseases, has increased dramatically over the last twenty years all over the world including Lithuania. Allergic diseases are associated...

Eligibility Criteria

Inclusion

  • I. Inclusion criteria:
  • Men and women between the ages of 18-50 years;
  • Allergic asthma (skin prick test positive for D. pteronyssinus, 5 grass mixture or birch pollen);
  • Symptoms more than one year;
  • Positive Bronchial challenge with methacholine or documented completely reversible bronchial obstruction;
  • Stable lung function (FEV1≥70 perc.);
  • Allergic rhinitis diagnosed according ARIA criteria.
  • Postmenopausal women. Premenopausal women if pregnancy test is negative
  • Healthy (subjects who are not sick with acute or chronic inflammatory, infectious, oncologic or immune diseases) - control group
  • Participants who gave his/her informed written consent.
  • II. Exclusion criteria
  • Asthma and rhinitis exacerbation;
  • Clinically significant permanent allergy symptoms (ex. cat or dog dander induced allergy);
  • Active airway infection 1 month prior the study;
  • Used medicaments:
  • Inhaled glucocorticoids intake 1 month prior the study;
  • Antihistamines intake 7 days prior the study;
  • Short acting β2 agonists 12 hours prior the study;
  • Long acting β2 agonists 2 days prior the study;
  • Leukotriene receptor antagonists prior 14 days;
  • If the histamine mean wheal diameter is \<= 3 mm or control mean wheal diameter is \>= 3 mm;
  • Psychiatric disorders;
  • Alcohol or narcotic abuse;
  • Pregnancy.
  • Breast-feeding.

Exclusion

    Key Trial Info

    Start Date :

    April 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2015

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT02214303

    Start Date

    April 1 2013

    End Date

    December 1 2015

    Last Update

    August 12 2014

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Lithuanian University of Health Sciences

    Kaunas, Lithuania, 50009